Helixor

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2015
02419802015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND AND AIM NK cells are one of the major immune cells in endometriosis pathogenesis. While previous clinical studies have… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
BACKGROUND Intratumoral (IT) injection of European mistletoe (Viscum album L) preparations might induce local tumor response… (More)
Is this relevant?
2014
2014
Background. Traditional mistletoe therapy in cancer patients involves subcutaneous applications of Viscum album L. preparations… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2007
2007
Mistletoe extracts are widely used in complementary and alternative cancer therapy in Europe. The extracts possess cytotoxic, as… (More)
  • table I
  • table II
  • table III
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Viscum album [L.] (VAL) extracts are widely used in adjuvant cancer therapy. These drugs were reported to exert effects of an… (More)
Is this relevant?
2006
2006
 
Is this relevant?
1999
1999
Drugs, which are effective are also bond to exert adverse effects. This is also true for mistletoe extracts. Extracts from… (More)
Is this relevant?
1990
1990
Helixor is an aqueous cold extract from fresh mistletoe, obtained from fir, pine and apple trees. A number of components with… (More)
Is this relevant?
1986
1986
The in vitro effectiveness of three Helixor preparations produced from mistletoes of different host trees on suspension cell… (More)
Is this relevant?
1980
1980
Helixor, a drug from the mistletoe, reduces in vitro the growth of the permanent human HeLa-cell line and the growth of the… (More)
Is this relevant?